arrow
A

Athena Matakidou

newcastle university - uk
H指数:34
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-13 C]pyruvate MRI

评估透明细胞肾细胞癌新辅助治疗的代谢效应:采用高极化[1-13 C]丙酮酸MRI

2025-12-010
OAAI
Investigating the mechanisms of neoadjuvant olaparib and cediranib in renal cancer: results of arms 1 to 3 of the WIndow of opportunity in REnal cancer (WIRE) clinical trial

探究新辅助奥拉帕利和西地尼布在肾癌中的作用机制:WIndow of opportunity in REnal cancer (WIRE) 临床试验第1至3组的试验结果

2025-10-010
OAAI
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol

WIRE研究使用贝叶斯自适应设计的II期,多臂,多中心,非随机的机会窗口临床试验平台,用于证明可手术肾细胞癌的新型治疗策略的机制-研究方案

2021-11-188
OAAI
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer (vol 46, pg 736, 2014)
2017-04-017
OAAI
Germline polymorphisms and survival of lung adenocarcinoma patients: A genome-wide study in two European patient series
2014-09-1923
OA
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer
2014-06-01360
OAAI